Eyal Desheh
2017
In 2017, Eyal Desheh earned a total compensation of $4.2M as Former Group Executive Vice President and Chief Financial Officer at Teva Pharmaceutical Industries, a 8% increase compared to previous year.
Compensation breakdown
| Option Awards | $666,686 |
|---|---|
| Salary | $831,428 |
| Stock Awards | $1,333,315 |
| Other | $1,369,101 |
| Total | $4,200,530 |
Desheh received $1.4M in other compensation, accounting for 33% of the total pay in 2017.
Desheh also received $666.7K in option awards, $831.4K in salary and $1.3M in stock awards.
Rankings
In 2017, Eyal Desheh's compensation ranked 2,406th out of 14,666 executives tracked by ExecPay. In other words, Desheh earned more than 83.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,406 out of 14,666 | 84th |
Division Manufacturing | 849 out of 5,770 | 85th |
Major group Chemicals And Allied Products | 223 out of 2,074 | 89th |
Industry group Drugs | 170 out of 1,730 | 90th |
Industry Pharmaceutical Preparations | 135 out of 1,329 | 90th |
Source: SEC filing on April 25, 2018.
Desheh's colleagues
We found nine more compensation records of executives who worked with Eyal Desheh at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries